Cancer Drugs Market Research Reports

"...... ushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. Panjin Gerun Biotech, Ajinomoto, Acetar Bio-Tech, Golden Horizon Biologics and Johncan Mushroom Bio-technology occupy the majority of lentinan......"

"...... malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Global Cancer Treatment Drugs key players include Roche,......"

"...... cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-r......"

"...... rapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol". North Am......"

"...... of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein. Chin......"

"...... with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Neutropenia Drugs market, with a systematical description of the stat......"

"...... loma, Prostate Cancer and Others, are propelling Small Molecule Cancer Drug market. Cytokine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Humanized ......"

"...... Cancer and Gastrointestinal Cancers, are propelling 5-Fluorouracil market. Injectables, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Capsules segmen......"

"...... lling Carboplatin market. Carboplatin Crystal, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Carboplatin Powder segment is estimated at % CAGR for the......"

"...... CAGR of 2.68% during the forecast years. Temozolomide is a chemotherapy drug. It is also called Temodal. Temozolomide is used to treat certain types of brain tumors. Temozolomide belongs to a class of drugs called alkylating agents. Te......"